BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10378199)

  • 1. Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria.
    Fisberg RM; Da Silva-Femandes ME; Fisberg M; Schmidt BJ
    Nutrition; 1999 Jun; 15(6):449-52. PubMed ID: 10378199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc and copper status of treated children with phenylketonuria.
    Acosta PB; Fernhoff PM; Warshaw HS; Hambidge KM; Ernest A; McCabe ER; Elsas LJ
    JPEN J Parenter Enteral Nutr; 1981; 5(5):406-9. PubMed ID: 7198157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil.
    Barretto JR; Silva LR; Leite ME; Boa-Sorte N; Pimentel H; Purificação AC; Carvalho G; Fontes MI; Amorim T
    Nutr Res; 2008 Mar; 28(3):208-11. PubMed ID: 19083409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace element nutrition status and dietary intake of children with phenylketonuria.
    Reilly C; Barrett JE; Patterson CM; Tinggi U; Latham SL; Marrinan A
    Am J Clin Nutr; 1990 Jul; 52(1):159-65. PubMed ID: 2360545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of treatment on zinc, copper and calcium status in children with phenylketonuria.
    Taylor CJ; Moore G; Davidson DC
    J Inherit Metab Dis; 1984; 7(4):160-4. PubMed ID: 6441863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc status and growth of children undergoing treatment for phenylketonuria.
    Acosta PB; Fernhoff PM; Warshaw HS; Elsas LJ; Hambidge KM; Ernest A; McCabe ER
    J Inherit Metab Dis; 1982; 5(2):107-10. PubMed ID: 6820419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
    Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral status in children with phenylketonuria--relationship to nutritional intake and phenylalanine control.
    McMurry MP; Chan GM; Leonard CO; Ernst SL
    Am J Clin Nutr; 1992 May; 55(5):997-1004. PubMed ID: 1570811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
    Iskra M; Majewski W
    Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of copper,zinc-superoxide dismutase in erythrocytes and ceruloplasmin in serum in chronic ischemia of lower limbs.
    Iskra M; Majewski W
    Int J Clin Lab Res; 1999; 29(2):64-7. PubMed ID: 10436263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge.
    Evans S; Daly A; MacDonald J; Preece MA; Santra S; Vijay S; Chakrapani A; MacDonald A
    Ann Nutr Metab; 2014; 65(1):42-8. PubMed ID: 25196394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition studies in treated infants and children with phenylketonuria: vitamins, minerals, trace elements.
    Acosta PB
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S136-9. PubMed ID: 8828630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide dismutase activity and zinc and copper concentrations in growth retardation.
    Kocatürk PA; Kavas GO; Erdeve O; Siklar Z
    Biol Trace Elem Res; 2004; 102(1-3):51-9. PubMed ID: 15621927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune status of children with phenylketonuria.
    Gropper SS; Chaung HC; Bernstein LE; Trahms C; Rarback S; Weese SJ
    J Am Coll Nutr; 1995 Jun; 14(3):264-70. PubMed ID: 8586776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and erythrocyte zinc, copper and selenium in cystic fibrosis.
    Neve J; Van Geffel R; Hanocq M; Molle L
    Acta Paediatr Scand; 1983 May; 72(3):437-40. PubMed ID: 6880733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. Effect of diabetic treatment on examined parameters].
    Zbrońska H; Grzeszczak W; Jendryczko A; Zbroński R; Kuźniewicz R
    Pol Arch Med Wewn; 1995 Sep; 94(3):228-34. PubMed ID: 8596760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trace element status of children with PKU and normal children.
    Gropper SS; Acosta PB; Clarke-Sheehan N; Wenz E; Cheng M; Koch R
    J Am Diet Assoc; 1988 Apr; 88(4):459-65. PubMed ID: 3351165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium, zinc and copper in Down's syndrome (trisomy 21): blood levels and relations with glutathione peroxidase and superoxide dismutase.
    Nève J; Sinet PM; Molle L; Nicole A
    Clin Chim Acta; 1983 Sep; 133(2):209-14. PubMed ID: 6226457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients.
    van Bakel MM; Printzen G; Wermuth B; Wiesmann UN
    Am J Clin Nutr; 2000 Oct; 72(4):976-81. PubMed ID: 11010940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.